Table of Contents
Why is the valuation of a medical company different from that of an ordinary company?
The value of a healthcare company is usually closely related to its technology platform, R&D pipeline, clinical data, commercialization capabilities, and future market space.
Therefore, the valuation of a medical company cannot simply apply the valuation methods of traditional manufacturing or general consumer companies.
Common Medical Company Valuation Methods
rNPV
The risk-adjusted net present value method is mainly used for R&D-based companies such as innovative drug companies.
Comparable Company Analysis
This method values the target company by selecting listed companies or transaction cases that are comparable in terms of business model, products, and development stage.
Precedent Transaction Analysis
This method assists in judging the value of a company by analyzing historical financing, M&A, and other similar transactions.
How should a company choose a valuation method?
In actual transactions, it is usually necessary to combine multiple methods rather than relying on a single valuation model.
The R&D stage of the company, the competitive landscape of its products, its commercialization capabilities, and the capital market environment will all affect the final valuation.